Lyphe Group (“Lyphe”), one of the UK’s leading medical cannabis companies, is pleased to announce an innovative partnership set to enhance the way patients receive their medical cannabis prescriptions.

In an industry first, Lyphe’s dispensing pharmacy Dispensary Green has partnered with Boveda Inc. (“Boveda”), the global leader in 2-way humidity control, to empower patients to keep their cannabis prescriptions in optimal condition.

As part of the partnership, Dispensary Green will include complimentary Boveda packs with all medical cannabis flower prescriptions. Dispensary Green and Boveda will also work together to educate patients on how to preserve the freshness of their medication and identify key quality markers.

Nick Pateras, CEO of Lyphe Group, said: “This partnership exemplifies our commitment to supporting patients’ rights for the highest quality medical cannabis.

“Our ambition to deliver a best-in-class patient experience has led us to identify several opportunities for standout patient care, and our relationship with Boveda is the first of these initiatives. We understand the importance of patients’ medicine being at its freshest and most effective for the conditions they are treating.”

Benjamin Patock, Head of International Relations at Boveda Inc., adds: “Proper humidification is one of the most pressing global challenges in cannabis care today, especially since it extends beyond the point of sale into patients’ homes – and therefore beyond the direct control of producers, clinics, and pharmacies.

“It is a pleasure to see medicinal pioneers such as Lyphe Group taking this extra step towards a flawless patient experience by embracing our patented technology. We are looking forward to a great partnership!”

CBD company CiiTECH has been sold to fellow UK-based cannabis company Tenacious Labs for £210,000.

In July 2021 CiiTECH raised £2.1m to fund its listing on the London Stock Exchange with a slated value of £17.5m.

However, after two loss-making years it fell into administration on October 22, 2022, and on February 16, this year, it was sold to Tenacious Halfway – a subsidiary of Tenacious Labs – for £210,000.

Administrators Leonard Curtis said it had received 46 expressions of interest in buying the assets of the business, which resulted in five offers with Tenacious making the highest bid.

Nick Morland, CEO and co-founder of Tenacious Labs, told Business of Cannabis: “CiiTECH was in the same situation as a couple of dozen good businesses. The irony is that they got hit the hardest as they were busy on the next step (an LSE listing).

Read more

https://businessofcannabis.com/ciitech-bought-out-of-administration-by-fellow-uk-company-for-21000/?mc_cid=c0a48fdbf5

PORTLAND, Oregon—March 1, 2023—Regulatory compliance firms Allay Consulting and The GMP Collective are joining forces amid the rapid national growth of the cannabis, hemp and emerging psychedelics sectors, with a focus on current Goods Manufacturing Practices (cGMP) compliance. This partnership empowers Allay Consulting to leverage its expertise in hands-on business consulting with support of policy and standards experts from The GMP Collective.

Through this partnership, The GMP Collective will now have increased availability to focus on working with governments, standards bodies such as ASTM International and ancillary service providers to lead the development of a cohesive regulatory framework that will align the disjointed statutes of the cannabis and hemp industries, both domestically and internationally.

“It’s not often you find competitors that want to share space together, much less the same business. With Allay Consulting and The GMP Collective, it has been quite the opposite,” said Kim Stuck, Allay Consulting CEO. “Both companies are composed of great minds trying to make it a better place for cannabinoid and breakthrough psilocybin companies, and it just made sense to work together.”

Both firms have long shared similar missions, and now business leaders will have increased access to professionals who have deep expertise in the regulatory world paired with experience working with the U.S. Food and Drug Administration (FDA) and all levels of state and municipal governments. Allay Consulting will oversee operational compliance solutions, including cGMP adherence, with individual operators, and The GMP Collective will focus on harmonizing and increasing clarity on policy and regulations through consensus standards development. This enables strategic advising support for businesses to position themselves as industry leaders which is a core component of cGMP and operational compliance work that Allay Consulting is implementing.

“For those that know us, this should come as no surprise. Every interaction with the Allay Consulting team has always been a positive one,” said David Vaillencourt, President of The GMP Collective and Senior Quality Consultant. “Taking the next step in our relationship, collaborating more closely as industry thought leaders and watching businesses benefit through global harmonization of cannabis regulations is a game changing opportunity.”

When a company utilizes the services of Allay Consulting or The GMP Collective, they now have the backing of a deep roster of compliance experts. The increased strength of these teams through partnership allows better support for clients and these industries overall.

About Allay Consulting

Whether your business involves CBD, THC, derivative cannabinoids, or psychedelics, Allay Consulting serves these industries to ensure regulatory compliance across all operations. We work with cultivators, manufacturers, retailers, investors and other stakeholders across the U.S. to develop customized strategies and avoid compliance pitfalls. Drawing from years of experience working on the regulatory side of the equation, our team is well-versed in rulemaking lingo and best practices, from product and food safety, to cGMP and ISO certifications, to OSHA and due diligence audits. Comprehensive knowledge of evolving regulations and unwavering attention to detail are central to Allay Consulting. We put your compliance worries to bed so you can focus on your products and services. 

About The GMP Collective

The GMP Collective is a team of experts leading the hemp and cannabis industries through engagement with regulators, trade organizations, and standards development organizations like ASTM International. We specialize in building a unique ecosystem of subject matter experts with diverse backgrounds and a passion for cannabis products that provide our clients with unrivaled knowledge and success. We are problem solvers, scientists, engineers, business owners—all united by our mission to ensure the quality, compliance, and safety of products containing cannabinoids.